SAN DIEGO -- August 11, 2003 -- Qualcomm Incorporated (Nasdaq: QCOM), pioneer and world leader of Code Division Multiple Access (CDMA) digital wireless technology, together with CardioNet, a provider of mobile outpatient cardiac telemetry technology and services, today announced that CardioNet's cardiac monitoring service has been enabled with Qualcomm's CDMA technology and wireless networking services. Qualcomm is providing the QConnect wireless network management service to provide connectivity between the CardioNet mobile monitoring devices and the CardioNet Monitoring Center.
Qualcomm's QConnect service provides the back-end infrastructure and network management service that allows the device to wirelessly transmit patient ECG data to the CardioNet Monitoring Center, and ultimately deliver succinct, timely information to physicians for diagnosis and therapy management. The wireless service also allows physicians to select events to be monitored and the level and timing of response by the CardioNet Monitoring Center - from routine daily reporting to detailed statistical reports. These reports, available by Internet, email, fax, or mail, have been designed to allow rapid review of cardiac arrhythmia events, assisting physicians in making a diagnosis, assessing the severity of a known cardiac rhythm problem, or in managing treatment.
"For over 14 years, Qualcomm has been supplying reliable, always-on wireless monitoring and data management solutions to corporations worldwide," said Chris Wolfe, president of Qualcomm Wireless Business Solutions. "We look forward to working with CardioNet to bring the benefits of CDMA wireless technology, as well as our proven network operations expertise and services to the health care market."
"Because many heart rhythm problems occur infrequently, continuous access to ECG information, as the patient goes about normal daily activities, is key in diagnosing and treating cardiac arrhythmias. A recent clinical study showed that CardioNet discovered significant, previously undetected cardiac problems in 53% of patients who had been unsuccessfully monitored through other methods," said James M. Sweeney, chairman and chief executive officer of CardioNet. "In the development of the CardioNet wireless solution, we looked for a provider with proven and reliable technology. Qualcomm's reputation as a leading provider of wireless data communications systems made it stand out as the provider of choice."
CardioNet is the first company to develop and introduce a fully mobile, continuous cardiac monitoring service - allowing heartbeat-by-heartbeat ECG monitoring, as patients go about their daily activities. The company is currently focused on helping physicians detect and treat cardiac arrhythmias, which often occur too infrequently to be diagnosed by short term testing in hospital emergency rooms or physicians' offices.
Qualcomm is the industry's global leader in providing high-value wireless data solutions with a Network Management Center that processes more than seven million transactions each day. Qualcomm has shipped nearly 479,000 mobile communication systems to businesses in more than 39 countries on four continents.
Qualcomm Incorporated (www.qualcomm.com) is a leader in developing and delivering innovative digital wireless communications products and services based on the Company's CDMA digital technology. Headquartered in San Diego, Calif., Qualcomm is included in theS&P500 Index and is a 2003 FORTUNE 500® company traded on The Nasdaq Stock Market® under the ticker symbol QCOM.
Except for the historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties, including the extent and speed to which the QConnect service is deployed, change in economic conditions of the various markets the Company serves, as well as the other risks detailed from time to time in the Company's SEC reports, including the report on Form 10-K for the year ended September 30, 2002, and most recent Form 10-Q.